ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1344	National Cancer Institute	Html	en	How To Handle Withdrawal Symptoms and Triggers When You Decide To Quit Smoking	This fact sheet provides helpful tips related to smoking cessation.	routine smoke breaks 0.282965 smoking effects 0.278771 relaxation techniques 0.313407 nicotine addiction 0.355656 Control Research Branch 0.30123 Yes. Nicotine replacement 0.344131 nicotine withdrawal symptoms 0.36823 urge 0.354906 tips 0.337093 negative feelings 0.295635 Nicotine nasal spray 0.380205 tea 0.279209 Tobacco Control Research 0.298555 things 0.265705 tobacco smoke 0.262113 nicotine replacement therapy 0.347084 drinking coffee 0.292775 highly dependent smokers 0.261935 daily life 0.289451 Smoking Quitline 0.271985 Step-by-Step Quit Guide 0.333256 nicotine replacement products 0.922705 help quitting tobacco 0.287795 nicotine replacement product 0.346885 smoking increase 0.274802	weight gain 0.385772 smokers 0.365077 counter weight gain 0.289631 nicotine cravings 0.53551 nicotine doses 0.315612 common negative feelings 0.293918 smoking 0.59993 nicotine lozenge 0.318321 nicotine inhaler 0.328106 nicotine travels 0.313333 nicotine level drops 0.347286 chews nicotine gum 0.341989 people 0.407906 strong urge 0.298124 physical activity 0.320031 people smoking 0.295038 nicotine gum 0.386182 nicotine patch 0.339006 withdrawal symptoms 0.655994 common withdrawal symptoms 0.360181 coffee 0.312007 smoking cessation trials 0.292819 Occasional mild cravings 0.284899 time 0.303672	CLICK HERE
1356	National Cancer Institute	Html	en	Carcinoma of Unknown Primary Treatment (PDQ®)–Patient Version	Expert-reviewed information summary about the treatment of metastatic cancer that has spread from an unidentified primary tumor.	general cancer information 0.411851 treatment 0.656267 cancer treatment 0.493001 breast cancer cells 0.486603 primary cancer 0.600191 new cancer treatments 0.408458 Peritoneal Cancer Treatment 0.426103 cancer cells 0.712358 tissue 0.443805 malignant tumor cells 0.423112 body 0.560831 type 0.447878 Cancer Information Service 0.414189 Squamous Neck Cancer 0.400297 PDQ cancer information 0.512966 clinical trial search 0.39505 treatment clinical trials 0.437756 certain changes 0.407705 National Cancer Institute 0.54586 clinical trials 0.823063 normal cells 0.410928 cancer information summary 0.471688 clinical trial 0.588388 new treatment 0.44726	breast cancer prevention 0.400005 primary cancer site 0.517081 cancer tissue 0.403216 patients 0.429603 Cancer Care page 0.397493 PDQ summary 0.435669 treatment clinical trial 0.401935 PDQ Adult Treatment 0.398071 NCI PDQ cancer 0.432436 cancer research process 0.400715 cancer clinical trials 0.44656 tests 0.388491 lymph nodes 0.409196 Unknown Primary Treatment 0.395812 carcinoma 0.39749 primary cancer depend 0.439856 lymph node 0.431668 radiation therapy 0.485838 Treatment Editorial Board 0.413559 cancer information summaries 0.411898 comprehensive cancer information 0.411754 cancer 0.945761 standard treatment 0.426236	CLICK HERE
1495	National Cancer Institute	Html	en	Hairy Cell Leukemia Treatment (PDQ®)–Health Professional Version	Expert-reviewed information summary about the treatment of hairy cell leukemia.	purine analog therapy 0.544174 BRAF inhibitor 0.537215 overall response rate 0.600065 cell leukemia patients 0.629349 purine analogs 0.574118 Hot Flashes 0.53761 complete remission rate 0.547966 long-term follow-up 0.53699 long term follow-up 0.54098 Tiacci et al. 0.545702 Foucar MK 0.540256 classic-form hairy cell 0.592078 cell leukemia variants. 0.563299 peripheral blood counts 0.541349 Pettirossi et al. 0.546064 median overall survival 0.57455 9-year median follow-ups 0.545986 patients 0.634056 continuous infusion 0.540582 multicenter studies 0.537514 VH4-34+ hairy cell 0.567746 B-cell lymphomas 0.539052 Rosenberg et al. 0.545728 Natl Cancer Inst 0.537773	hairy-cell leukemia 0.564359 Night Sweats 0.538245 et al. 0.547621 median treatment-free survival 0.574134 partial remission rate 0.543701 stable partial remission 0.545722 cladribine 0.537399 complete remissions 0.537086 one-time continuous infusion 0.53916 comparable response rates 0.548208 treatment option 0.539331 median follow-up 0.54766 potential increased risk 0.575127 cell leukemia variant 0.57205 overall response rate. 0.539597 complete response rate 0.636139 Abstract 0.548918 hairy cell leukemia 0.918712 Clin Oncol 0.592807 subcutaneous injections 0.544059 PDQ summary 0.53807 cell leukemia variants 0.563543 previously untreated patients 0.548389 standardized incidence ratio 0.536889	CLICK HERE
1675	National Cancer Institute	Html	en	Lymphedema (PDQ®)–Health Professional Version	Expert-reviewed information summary about the anatomy, pathophysiology, clinical manifestations, diagnosis, and treatment of cancer-related lymphedema, a condition in which lymph fluid builds up in tissues and causes swelling.	upper-limb lymphedema 0.596897 Manual lymphatic therapy 0.494091 axillary node dissection 0.485114 lymph nodes. 0.472628 upper-extremity lymphedema 0.68666 arm lymphedema 0.638618 lower-limb lymphedema 0.630542 lymph node dissection 0.832229 lower-extremity lymphedema 0.630897 deep lymphatic systems 0.498654 intestinal lymphatic trunk 0.501781 new lymphedema 0.619269 lumbar lymphatic trunk 0.502509 upper extremity lymphedema 0.623186 manual lymphatic drainage 0.477215 lymph collector vessels 0.497637 lymphatic vessels 0.762836 lymphedema onset 0.622585 secondary lymphedema 0.644407 certified lymphedema 0.696216 left subclavian vein 0.475686 lymphedema manifest 0.633761 lymphedema classification 0.594846 protein-rich lymph fluid 0.533977	secondary lymphatic vessels 0.59679 subclavian lymphatic trunk 0.576658 primary lymphatic vessels 0.596665 subcutaneous lymphatic vessels 0.50703 lymphedema 0.987634 breast cancer patients 0.473019 certified lymphedema therapist 0.652056 patients 0.478875 cancer patients 0.474035 Lymph channels 0.46738 lymph node biopsy 0.634545 breast cancer 0.848001 sentinel lymph node 0.728941 certified lymphedema therapists 0.649954 unidirectional lymphatic flow 0.496065 breast cancer survivors 0.505056 axillary lymph node 0.799687 lymph nodes 0.59192 treatable lymphedema 0.590609 lymph node biopsy. 0.539242 manual lymphedema therapy. 0.64813 lymph node drainage 0.539621 manual lymphedema therapy 0.852751	CLICK HERE
1765	National Cancer Institute	Html	en	Physical Activity and Cancer	A fact sheet that summarizes evidence linking exercise and other physical activity, including work and household chores, to reduced cancer risks.	U. Physical activity 0.367372 bone-strengthening physical activity 0.370971 physical activity daily 0.371076 physical activity attenuate 0.362897 better breast cancer 0.3594 low physical activity 0.37763 Breast Cancer Research 0.357155 muscle-strengthening physical activity 0.370998 vigorous physical activity 0.364437 S. Physical activity 0.365821 average breast cancer 0.365315 cancer risk reduction 0.373439 colorectal cancer 0.41572 average endometrial cancer 0.357301 H. Physical activity 0.366033 postdiagnosis physical activity 0.363749 postmenopausal breast cancer 0.379275 lower risk 0.357009 potential physical activity 0.369413 physical activity influence 0.360893 different cancer risk 0.360424 aerobic physical activity 0.386234 vigorous-intensity physical activity 0.373987 cancer survivors 0.406644 Cancer Epidemiology 0.363652	cancer prevention 0.376861 Physical Activity website 0.371276 A. Physical activity 0.364619 breast cancer diagnosis 0.4205 endometrial cancer risk 0.390992 breast cancer recurrence 0.359315 Physical Activity Guidelines 0.371598 links physical activity 0.369787 physical activity benefit 0.375758 National Cancer Institute 0.363045 daily physical activity 0.370902 L. Physical activity 0.366831 breast cancer risk 0.390634 colon cancer 0.375643 meta-analysis 0.376142 breast cancer 0.54813 colon cancer risk 0.372667 systematic review 0.435657 physical activity 0.996162 prostate cancer 0.369869 leisure-time physical activity 0.442557 et al 0.539243 cancer risk 0.441434 recreational physical activity 0.391568	CLICK HERE
2029	National Cancer Institute	Html	es	Prevención del cáncer de seno (mama) (PDQ®)–Versión para profesionales de salud	Sumario de información revisada por expertos sobre factores que influyen en el riesgo de presentar cáncer de mama y sobre las investigaciones dirigidas a la prevención de esta enfermedad.	Sestak I 0.314213 Methods Mol Biol 0.309681 menor incidencia 0.315649 Breast Cancer Surveillance 0.32247 largo plazo 0.325123 Risk Calculator 0.330192 Cuzick J 0.314017 breast cancer prevention 0.340448 útero intacto 0.328063 Estados Unidos 0.337849 menor riesgo 0.381674 cancer prevention trial 0.330827 Women's Health Initiative 0.311811 principal factor 0.31767 Health Initiative 0.316067 from benign breast 0.320129 Breast density 0.313434 lobular breast 0.315708 English record linkage 0.310983 hormonas estrógeno 0.31642 health study 0.316005 benign breast 0.353338 Cancer Res Treat 0.315355 Cancer Risk Assessment 0.316082 Epidemiol Biomarkers Prev 0.309854	enfermedad proliferativa benigna 0.311069 Goss PE 0.314786 antecedentes familiares 0.49279 Breast Risk Calculator 0.318395 prospective cohort study 0.311422 breast cancer risk 0.370651 reducción promedio 0.315263 breast cancer 0.951386 cardiopatía coronaria 0.328283 riesgos instantáneos 0.314306 IBIS-I breast 0.313331 risk factor 0.343815 mujeres portadoras 0.329041 Cancer Surveillance System 0.312955 IBIS Breast Cancer 0.320333 heritable risk factor 0.311842 Risk Calculator Tool 0.311 Reino Unido 0.311996 Women’s Health Initiative 0.309787 Breast Cancer Referral 0.321555 parenchymal patterns as 0.309616 Otro estudio 0.316688 Breast Cancer Res 0.357313 mujeres jóvenes 0.346647	CLICK HERE
2068	National Cancer Institute	Html	es	Marcadores de tumores	Hoja informativa que explica lo que son los marcadores de tumores y responde preguntas sobre su uso para el diagnóstico y tratamiento del cáncer.	Bast RC Jr 0.727949 cancer screening 0.603977 Gray RJ 0.462067 randomized european study 0.51305 Asociación Estadounidense 0.468124 estudio plco 0.461327 Bigbee W 0.467579 amplia gama 0.464843 afecciones benignas 0.671952 Herberman RB 0.469893 Prevention Research 0.463207 BC Decker Inc 0.509079 Clinical Laboratory Improvement 0.519898 Cancer Screening Randomized 0.544857 Controlled Trial 0.467216 riesgo intermedio 0.462476 Clinical Practice 0.47196 ecografía transvaginal 0.471751 Makower DF 0.466396 estudio tailorx 0.460805 ¿Cuáles marcadores 0.637902 21-gene expression assay 0.514014	Hugosson J 0.463892 Instituto Nacional 0.461324 screening trial specimens 0.541412 Oncología Clínica 0.463202 tumor markers 0.619108 Andriole G 0.463781 Mortality results from 0.526447 Quality Requirements 0.470424 Kufe DW 0.468535 Black A 0.461077 6th ed 0.467056 Oncotype DX® 0.469566 situaciones benignas 0.492829 PubMed Abstract 0.928354 tratamientos resultantes 0.466203 Buys SS 0.460749 Bioquímica Clínica 0.461341 Pollock RE 0.46616 New England Journal 0.930005 Roobol MJ 0.466517 Sparano JA 0.466154 hoja informativa estadificación 0.539118	CLICK HERE
2069	National Cancer Institute	Html	es	Enfermedad de Paget de seno	Hoja informativa sobre la enfermedad de Paget de seno, un tipo poco común de cáncer que algunas veces se llama enfermedad de Paget del pezón o enfermedad de Paget de mama.	Lippincott Williams 0.227873 Tumor Characteristics 0.23784 Eisner MP 0.227823 cáncer invasor 0.852818 afecciones benignas 0.232299 Cody HS 0.226638 Female Breast 0.245015 posibles tumores 0.243494 long-term follow-up study 0.244429 Breast Cancer Research 0.268606 siglo xix sir 0.249073 breast-conserving therapy 0.228801 Lippman ME 0.226791 ganglios linfáticos centinela 0.294176 afección benigna 0.309089 SEER Program 0.276615 Kanitakis J 0.22651 estadio i 0.22947 Hasson D 0.226314 European Institute 0.226377 Keel GE 0.226988 PubMed Abstract 0.996634 Haffty BG 0.225876 clinical presentation 0.228015 Therapeutic options 0.226841	with radiotherapy 0.228051 Tucker SL 0.226414 Paget mamaria 0.499743 estadio iv 0.228625 End Results 0.22623 Griffith KA 0.226914 signo revelador 0.231703 proteína her2 0.228884 National Cancer Institute 0.247867 4th ed 0.228822 Sosnovskikh I 0.226721 Ries LAG 0.280943 edad promedio 0.227469 Breast Journal 0.241614 Osborne CK 0.226941 Sir James Paget 0.694935 Cancer Survival Among 0.251885 estadio iii 0.228362 Gatti G 0.22751 Retrieved April 0.227819 sentinel lymph 0.278815 European Academy 0.22756 extramammary paget 0.443981 Dimaio DJ 0.226799	CLICK HERE
3582	National Cancer Institute	Html	en	Frederick National Laboratory for Cancer Research	The FNLCR combines private sector business practices with government infrastructure to conduct research and development in cancer and AIDS.	Frederick National Lab 0.679634 Development Center—one 0.586036 Federally Funded Research 0.723777 FNLCR 0.617129 biomarker identification 0.53533 animal sciences 0.53568 national resource 0.541398 government agencies 0.530109 human clinical trials 0.61809 preclinical assay development 0.712354 oncology-focused computational science 0.628628 cancer research laboratories 0.757218 early development 0.553877 research reagents 0.571396 NCI 0.666268 genetically engineered mouse 0.603734 preclinical research 0.638044 nonprofit research organizations 0.690454 broad charter 0.538883 Leidos Biomedical Research 0.735212 United States 0.647036 Nanotechnology Characterization Laboratory 0.625355 RAS family 0.527528 clinical practice 0.533965	NCI investigators 0.632716 significant cancer research 0.722685 translational genomics 0.544933 cancer research 0.952491 private sector business 0.653242 new drug development 0.647375 government sponsors 0.545164 biomedical research community 0.670235 development needs 0.584975 cancer researchers 0.562687 clinical operations 0.542191 Frederick National Laboratory 0.684108 government infrastructure 0.535486 technical staff 0.530406 preclinical model development 0.704349 private sector resources 0.635668 FNLCR programs 0.564698 National lab staff 0.628876 biomedical computing 0.548325 new cancer therapies 0.637914 frozen tumor samples 0.605424 nanotechnology applications 0.53469 cancer research enterprise 0.705608 basic research 0.59861	CLICK HERE
16886	National Cancer Institute	Html	en	Thyroid Cancer Screening (PDQ®)–Health Professional Version	Expert-reviewed information summary about tests used to detect or screen for thyroid cancer.	thyroid cancer trends 0.476323 thyroid tumors 0.422645 United States 0.468063 thyroid cancer screening. 0.46539 cancer registry data 0.363099 thyroid fine-needle aspiration 0.447959 opportunistic thyroid cancer 0.46743 thyroid cancer 0.931034 thyroid cancer incidence 0.631162 Thyroid Cancer Treatment 0.500772 Well-differentiated thyroid cancers 0.495048 palpation screening results 0.370878 total thyroidectomy 0.358528 cancer screening results 0.386186 radioactive iodine 0.350234 South Korea 0.456219 10-year relative survival 0.451331 frequently diagnosed cancer 0.37852 recurrent laryngeal nerve 0.36801 papillary thyroid cancer 0.525506 summary event measure 0.364067 free screening exams 0.364504 follicular thyroid cancers 0.495803 thyroid cancer mortality 0.490522	thyroid cancer overdiagnosis 0.479797 neck palpation 0.364787 cancer incidence rates 0.389027 thyroid cancer deaths. 0.489306 thyroid cancers cases 0.461202 thyroid cancer cases 0.467037 papillary thyroid cancers 0.524728 cancer diagnoses 0.354076 anaplastic thyroid cancers 0.495303 laryngeal nerve injury 0.368292 thyroid cancer screening 0.828908 thyroid cancers 0.597668 thyroid ultrasound 0.428817 suspicious screening result 0.361018 thyroid surgery 0.435882 population-based screening programs 0.366887 national cancer screening 0.412147 medullary thyroid cancer 0.491568 Cancer Screening Guidelines 0.39228 formal screening 0.347128 asymptomatic thyroid cancers 0.481523 incidental thyroid nodules 0.466527 vocal cord 0.353855	CLICK HERE